Mashup Score:8
Oncology Data AdvisorDiscussing the Relevance of Urine Studies in Myeloma With Kelsey Natsuhara, MD - 1 month
Mashup Score:8
# ASH22
Mashup Score:8
ash.confex.comWebprogram Unavailable - 1 month
Mashup Score:8
Webprogram is no longer available Please click HERE if you are not redirected in 5...
-
BMT w/in 4 wks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study [Sat, Dec 10, 2022] @MeeraMohanMD Abst 387 #ASH22 https://t.co/4MtPzSAUAs #COVID19nCancer #bmtsm #IDonc #COVID19 #AMLsm #leusm OR 49.6 📷 https://t.co/4MtPzSAUAs - view on twitter
Mashup Score:2
meetings.asco.orgProgram Guide – ASCO Meeting Program Guide - 2 weeks
Mashup Score:2
AuthorsJuan DuShanghai Changzheng Hospital, Shanghai, Shanghai, ChinaJuan Du, Wei-Jun Fu, Hua Jiang, Baoxia Dong, Li Gao, Li Liu, Jian Ge, Aili He, Lu Li,...
-
#mmsm #ASCO23 BCMA/CD19 dual-targeting CAR-T ➡️ https://t.co/IGPKsiG4GS 🛑presented #ASCO22 #ASH22 ✅continue to show some promise with high ORR , MRD-ve but I am concerned about presenting this every few months with few more pts(n=29) ✅median: DOR:37 mo,PFS:38 mo https://t.co/IGPKsiG4GS - view on twitter
Background: Belantamab mafodotin (belamaf) is a first-in-class antibody-drug conjugate (ADC) targeting B-cell maturation antigen (BCMA). Belamaf has shown...
-
@DrPaulyDeSantis @DrAlexisTalbot I like ALGONQUIN! From #ASH22 by Dr. Trudel @HiraSMian et al. Why have belantamab and pom-dex be foes when they could be friends 😉 https://t.co/mMyp88d8N5 - view on twitter
More coverage:
#ash22
Mashup Score:1
ash.confex.comWebprogram Unavailable - 4 weeks
Mashup Score:1
Webprogram is no longer available Please click HERE if you are not redirected in 5...
-
Global Treatment Standard in Multiple Myeloma Remains Elusive: Updated Results from the INSIGHT MM Global, Prospective, Observational Study [Dec 10, 2022] @NoemiPuigM et al. @BerdejaJesus Abs 1859 #ASH22 https://t.co/mCCkPgMebV #mmsm #globonc https://t.co/mCCkPgMebV - view on twitter
Webprogram Unavailable - 4 weeks
Webprogram is no longer available Please click HERE if you are not redirected in 5...
-
BMT w/in 4 wks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study [Sat, Dec 10, 2022] @MeeraMohanMD Abst 387 #ASH22 https://t.co/4MtPzSAUAs #COVID19nCancer #bmtsm #IDonc #COVID19 #AMLsm #leusm OR 49.6 https://t.co/4MtPzSAUAs - view on twitter
Kelsey Natsuhara discusses her presentation regarding the relevance of urine studies in myeloma patients undergoing...
3/ Pleasure mentoring @KelseyNatsuhara on this - she did an AMAZING job as a @UCSFCancer fellow and even got interviewed about her first-author #ASH22 abstract! https://t.co/wVxMZzdoso And 🙏 @ninashah33 and @SandyWong02111 for mentorship behind the scenes to make this happen! - view on twitter